CNRS Nantes University US2B US2B
home |  start a new run |  job status |  references&downloads |  examples |  help  

Should you encounter any unexpected behaviour,
please let us know.
 elNémo has been hacked on november 27th.
It has been moved away and runs again.
**Still some additional cleaning from time to time**
Sorry for the inconvenience.


***  IMMUNE SYSTEM 14-NOV-18 6N2U  ***

<R2> analysis for 2604131021151763097

---  normal mode 101  ---

This page gives a visualization of the normalized mean square displacement <R2> of all C-alpha atoms in the protein that are associated to this mode (black bars). The three components of the corresponding eigenvector are shown on the left (colored bars). Here is the raw data for <R2> and for the eigenvector (shift-click on the links for download).

XYZresidue<R2><R2>max = 0.0776
LYS 10.0042
GLU 20.0107
LEU 30.0198
ARG 40.0130
CYS 50.0088
GLN 60.0137
CYS 70.0177
ILE 80.0091
LYS 90.0250
THR 100.0470
TYR 110.0187
SER 120.0079
LYS 130.0524
PRO 140.0354
PHE 150.0141
HIS 160.0178
PRO 170.0084
LYS 180.0243
PHE 190.0182
ILE 200.0086
LYS 210.0098
GLU 220.0121
LEU 230.0131
ARG 240.0312
VAL 250.0206
ILE 260.0080
GLU 270.0082
SER 280.0068
GLY 290.0120
PRO 300.0070
HIS 310.0026
CYS 320.0063
ALA 330.0086
ASN 340.0066
THR 350.0063
GLU 360.0056
ILE 370.0073
ILE 380.0138
VAL 390.0112
LYS 400.0154
LEU 410.0190
SER 420.0329
ASP 430.0328
GLY 440.0305
ARG 450.0187
GLU 460.0156
LEU 470.0105
CYS 480.0182
LEU 490.0129
ASP 500.0186
PRO 510.0189
LYS 520.0088
GLU 530.0176
ASN 540.0232
TRP 550.0152
VAL 560.0152
GLN 570.0236
ARG 580.0229
VAL 590.0097
VAL 600.0069
GLU 610.0170
LYS 620.0079
PHE 630.0057
LEU 640.0249
LYS 650.0148
ARG 660.0206
ALA 670.0776
GLU 680.0284
ASN 690.0487

If you find results from this site helpful for your research, please cite one of our papers:

elNémo is maintained by Yves-Henri Sanejouand.
It was developed by Karsten Suhre.
Between 2003 and 2014, it was hosted by IGS (Marseille).
Between 2015 and 2025, it was hosted by US2B (Nantes).
Last modification: december 26th, 2025.